Example: stock market
Guideline on stability testing for applications for ...
1. Introduction (background) This guideline describes the stability testing requirements for variations to a marketing a uthorisation after approval.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Related documents
Annex 2 Stability testing of active pharmaceutical ...
apps.who.int89 2. Guidelines 2.1 Active pharmaceutical ingredient 2.1.1 General Information on the stability of the API is an integral part of the systematic approach to stability evaluation. Potential attributes to be …
STABILITY TESTING OF ACTIVE PHARMACEUTICAL ... - …
www.who.intWorking document QAS/17.694 page 5 102 Stability testing of active pharmaceutical ingredients and 103 finished pharmaceutical products 104 1. Introduction 1.1 Objectives of these guidelines105 106 1.2 Scope of these guidelines 107 1.3 General principles 108 2. Guidelines 109 2.1 Active pharmaceutical ingredient 2.1.1 General110 2.1.2 Stress testing111 112 2.1.3 Selection of batches
ISSN: 2231 Stability Testing of Pharmaceutical Products
japsonline.comJournal of Applied Pharmaceutical Science 02 (03); 2012: 129-138 ISSN: 2231 followed for stability testing of pharmaceutical products, guidelines issued for stability testing
Registration of Medicines Stability - ICH Official web site
www.ich.orgRegistration of Medicines Stability Stability v1.doc March 2004 1 SADC GUIDELINE FOR STABILITY TESTING 2004 This guideline is intended to provide requirements to applicants wishing to submit
Strategies for In Vitro Metabolic Stability Testing ...
www.bdbiosciences.comStrategies for In Vitro Metabolic Stability Testing Christopher Patten, PhD BD Biosciences December 2, 2009
Stability Existing Corrected March 2007 - ema.europa.eu
www.ema.europa.euCPMP/QWP/122/02, rev 1 corr EMEA 2007 3/18 STABILITY TESTING OF EXISTING ACTIVE SUBSTANCES AND RELATED FINISHED PRODUCTS 1. INTRODUCTION 1.1 …
Stability Testing of Pharmaceutical Products in a Global ...
www.who.intRegulatory Feature The stability of finished pharmaceutical products depends on environmental and product-related factors ICH and WHO started discussions in 2000 to